Latest Breaking News On - Scientific sessions of the american heart association - Page 1 : comparemela.com

Heart-1 Gene Therapy Trial Pauses Enrollment

A phase 1 gene editing trial in patients with heterozygous familial hypercholesterolemia and atherosclerotic CVD was paused after abnormal lab results were seen.

New zealandUnited statesUnited kingdomSekar kathiresanHealth canadaVerve therapeutics incDevices safety authorityDrug administrationRegulatory agencyScientific sessions of the american heart associationVerve therapeuticsScientific sessionsAmerican heart associationUnited kingdom medicinesNew zealand medicinesMedical devices safety

Longeveron Reports Year-End 2023 Results and Provides Corporate Update

Longeveron Reports Year-End 2023 Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMike moyerExchange commissionAmerican heart associationLongeveron incDevelopment expensesLongeveron or companyCompany to hold conference callExchange commission onScientific sessions of the american heart associationReports year endProvides corporatePriorities focusedHypoplastic left heartStudy enrollment anticipatedSurvival data

Element Science s slim cardioverter defibrillator patch claims European approval

Element Science s slim cardioverter defibrillator patch claims European approval
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Czech republicUnited statesUday kumarScientific sessions of the american heart associationElement scienceScience presidentAnnual scientific sessionsAmerican heartDeerfield healthcareQiming venture partners united statesCormorant asset managementInvus opportunitiesGoogle venturesThird rock ventures

Long-term Survival Data from Longeveron s ELPIS 1 Trial Presented at the 2023 Scientific Sessions of the American Heart Association – IT Business Net

Long-term Survival Data from Longeveron s ELPIS 1 Trial Presented at the 2023 Scientific Sessions of the American Heart Association – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesSunjay kaushalMike moyerDrug administrationBlood instituteLongeveron incNational heartCompany quarterlyScientific sessions of the american heart associationLongeveron or companyNational institute of health heartExchange commissionExtended follow up data show continuedTransplant free survivalSupport continued investigationAging related frailty

Long-term Survival Data from Longeveron s ELPIS 1 Trial Presented at the 2023 Scientific Sessions of the American Heart Association

Long-term Survival Data from Longeveron s ELPIS 1 Trial Presented at the 2023 Scientific Sessions of the American Heart Association
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesContactmike moyerlifesci advisorstelSunjay kaushalNational institute of health heartCompany quarterlyLongeveron incLongeveron or companyNational heartBlood instituteScientific sessions of the american heart associationDrug administrationExchange commissionExtended follow up data show continuedTransplant free survivalSupport continued investigationAging related frailty